Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Winmark
WINA
$1.24B
| $961K | ﹤0.01% |
3,022
-48,720
| -94% | -$17.4M |
|
2777
Bausch Health
BHC
$2.32B
| $958K | ﹤0.01% |
148,006
+1,169
| +0.8% | +$8.4K |
|
|
NCZ
2778
Virtus Convertible & Income Fund II
NCZ
$306M
| $956K | ﹤0.01% |
82,715
+18,519
| +29% | +$231K |
|
|
OLO
2779
DELISTED
Olo Inc
OLO
| $953K | ﹤0.01% |
157,732
+36,121
| +30% | +$252K |
|
2780
Celldex Therapeutics
CLDX
$3.52B
| $952K | ﹤0.01% |
52,443
+10,342
| +25% | +$231K |
|
2781
CRISPR Therapeutics
CRSP
$5.22B
| $951K | ﹤0.01% |
27,957
-5,833
| -17% | -$247K |
|
2782
Immunovant
IMVT
$8.8B
| $945K | ﹤0.01% |
55,312
-448,720
| -89% | -$9.39M |
|
2783
iHeartMedia
IHRT
$449M
| $945K | ﹤0.01% |
572,595
-112,474
| -16% | -$226K |
|
2784
Napco Security Technologies
NSSC
$1.39B
| $944K | ﹤0.01% |
41,016
+5,279
| +15% | +$150K |
|
2785
Syndax Pharmaceuticals
SNDX
$1.77B
| $944K | ﹤0.01% |
76,848
+25,524
| +50% | +$360K |
|
2786
Haverty Furniture Companies
HVT
$441M
| $943K | ﹤0.01% |
47,839
-4,599
| -9% | -$101K |
|
2787
Gray Television
GTN
$501M
| $942K | ﹤0.01% |
218,157
+66,744
| +44% | +$262K |
|
|
TSE
2788
DELISTED
Trinseo
TSE
| $941K | ﹤0.01% |
255,668
-58,990
| -19% | -$268K |
|
2789
Vanda Pharmaceuticals
VNDA
$314M
| $941K | ﹤0.01% |
204,964
-23,384
| -10% | -$109K |
|
|
ACCD
2790
DELISTED
Accolade Inc
ACCD
| $940K | ﹤0.01% |
134,601
+55,877
| +71% | +$374K |
|
|
BRY
2791
DELISTED
Berry Corp
BRY
| $933K | ﹤0.01% |
290,517
-15,614
| -5% | -$64K |
|
2792
Zymeworks
ZYME
$1.77B
| $931K | ﹤0.01% |
78,206
+8,824
| +13% | +$120K |
|
|
ACRE
2793
Ares Commercial Real Estate
ACRE
$261M
| $930K | ﹤0.01% |
200,847
-24,139
| -11% | -$128K |
|
2794
Funko
FNKO
$332M
| $930K | ﹤0.01% |
135,538
-15,233
| -10% | -$177K |
|
2795
Financial Institutions
FISI
$824M
| $928K | ﹤0.01% |
37,189
-1,650
| -4% | -$44.6K |
|
2796
The RealReal
REAL
$1.36B
| $924K | ﹤0.01% |
171,417
-882,494
| -84% | -$6.69M |
|
2797
Vaalco Energy
EGY
$601M
| $923K | ﹤0.01% |
245,571
-14,947
| -6% | -$62.3K |
|
|
ETWO
2798
DELISTED
E2open Parent Holdings
ETWO
| $922K | ﹤0.01% |
461,238
-47,030
| -9% | -$117K |
|
2799
E.W. Scripps
SSP
$316M
| $921K | ﹤0.01% |
311,269
-28,584
| -8% | -$62.5K |
|
2800
El Pollo Loco
LOCO
$464M
| $921K | ﹤0.01% |
89,416
-9,313
| -9% | -$105K |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.